FIELD: biotechnology.
SUBSTANCE: following is provided: a modified VP1 AAVrh74 capsid protein for increased gene delivery comprising either one or more modifications selected from isoleucine to asparagine substitution at amino acid position 502, tryptophan to arginine substitution at position 505 of VP1 AAVrh74, and insertion of a YIG or YIGSR peptide (SEQ ID NO: 2) to the position of amino acid 591 VP1 of AAVrh74 or their equivalents. Also a recombinant viral particle for increased gene delivery containing a modified AAVrh74 VP1 is presented. Besides, a polynucleotide encoding a modified AAVrh74 VP1 and a gene delivery vector containing said polynucleotide are described. A polynucleotide encoding a recombinant viral particle and a gene delivery vector containing the described polynucleotide, as well as a recombinant expression system containing the described polynucleotide, a recombinant expression system containing the vector are described. Also a host cell containing a polynucleotide is provided. A method of modifying a polynucleotide in a cell or in a subject, which includes delivering an effective amount of a recombinant viral particle into the cell is described. A kit for modifying a polynucleotide, including a recombinant viral particle is presented.
EFFECT: invention expands the arsenal of agents for therapeutic use.
19 cl, 5 dwg, 1 tbl, 1 ex
| Title |
Year |
Author |
Number |
| RECOMBINANT ADEN-ASSOCIATED VIRUS, WHICH IS HYBRID OF AAV9 AND AAVrh74 SEROTYPES, WITH REDUCED TROPISM FOR LIVER TISSUE |
2019 |
- Rishar, Izabel
- Zhikkel, Evelin
- Mingotstsi, Federiko
- Rontsitti, Dzhuzeppe
- Vidal, Patris
|
RU2812279C2 |
| VARIANT AAV, COMPOSITIONS AND METHODS, IN WHICH IT IS USED, AS WELL AS METHODS OF ITS APPLICATION FOR TRANSFER OF GENES INTO CELLS, ORGANS AND TISSUES |
2014 |
- Khaj Ketrin A.
- Yazisioglu Mustafa N.
- Angela Khaver
|
RU2697444C2 |
| METHODS FOR ENHANCING BIOLOGICAL ACTIVITY OF RECOMBINANT ADENO ASSOCIATED VIRUS PRODUCED BY BACULOVIRUS SYSTEM |
2017 |
- Zolotukhin, Sergej
- Kondratov, Oleksandr
|
RU2762948C2 |
| VERSION OF AAV, COMPOSITIONS AND METHODS IN WHICH IT IS USED, AS WELL AS METHODS OF USING IT FOR TRANSFERRING GENES INTO CELLS, ORGANS AND TISSUES |
2014 |
- High, Katherine A.
- Yazicioglu, Mustafa N.
- Anguela, Xavier
|
RU2837753C2 |
| GENE THERAPY VECTORS FOR TREATING DANON'S DISEASE |
2020 |
- Keravala, Annahita
- Prabhakar, Raj
- Shah, Gaurav
- Wong, Roderick
- Yalamanchi, Naveen
- Pratumsuwan, Piratip
|
RU2822925C2 |
| ADENO-ASSOCIATED VIRUS VECTOR |
2015 |
|
RU2743382C2 |
| MODIFIED FREEDREICH ATAXY GENES AND VECTORS FOR GENE THERAPY |
2016 |
|
RU2743792C2 |
| VECTORS CONTAINING SPACER/FILLER POLYNUCLEOTIDE SEQUENCES, AND METHODS OF USING THEM |
2014 |
- Rajt Dzh. Frejzer
- Zelenaya Olga
|
RU2725813C2 |
| AAV MUTANT WITH ABILITY TO TARGET BRAIN |
2020 |
- Nishie, Toshikazu
- Takashima, Fuyuko
- Enoki, Tatsuji
- Mineno, Junichi
- Tanaka, Yoshinori
|
RU2809389C2 |
| MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE |
2016 |
- Khaj Ketrin A.
- Angela Khaver
|
RU2811445C2 |
